Anonymous
Guest
Anonymous
Guest
Can anyone confirm how things are going for this contract? Seems like a really good up and coming company.
I was also wondering what the deal was with Exact after the fact also but the chatter on here is nowhere to be found strange ! I interviewed but ended up at a non CSO job after going through the process with Quintiles. The comp for this contract was base 70k and 15K yr 1 bonus which was lower than I thought they would pay but it is CSO. Maybe the comp has changed ? I think this has potential but it's a 2yr contract (yes there is rollover for some but when ?) and you have to think EXAS wants to put as much $ in their pocket as possible. Hence in terms of being generous with reps I don't see EXAS doing that till at least a yr plus out from now but maybe I'm off on that who knows. They need Cologuard to bring in significant $ first and foremost.
For reps who are on this contract, I would keep interviewing. Sounds very promising but until they commit, i.e., rollover as Exact employees with stake in overall success like stock options, there is no trust/loyalty on both sides.
Is the base the same for Quintiles reps and direct hires? I was told 70-75k
They are hiring 40 new reps, no 'chopping'. Above poster, no sheet, they didn't want diagnostic reps!!
Exact Sciences just chopped the majority of sales force with no explanation.
The sales management in inept, no one knows what they are doing, and there is little to no communication.
I am one of the lucky ones who survived the mass firing, but I am looking for a new job asap.
Investors are getting the wool pulled over their eyes.
There are thousands of orders they have lost track of, since everything in order tracking is manual, and I have witnessed results with private health information being sent to the wrong offices. Their compliance is significantly lacking and orders sit for months and months with nothing being done.
It falls back on the clinic staff to do the work. Before the office used to make money for each FIT test, now they making nothing, and have more work to administer the test orders.
This is a bogus test. The last two versions of the same test produced worthless results, and now after adding a FIT test and some stabilizer they got lucky and got the results above 90%.
We are only talking about a difference of 2 patients in a 12,000 patient trial. If they had missed just one less patient, the product would have been a bust (for the 3rd time). And remember the test design relies upon a colonoscopy that could be doctored.
This test has pulled the eyes over on the FDA and CMS and will lead patients into a false sense of security.
Exact Sciences just chopped the majority of sales force with no explanation.
The sales management in inept, no one knows what they are doing, and there is little to no communication.
I am one of the lucky ones who survived the mass firing, but I am looking for a new job asap.
Investors are getting the wool pulled over their eyes.
There are thousands of orders they have lost track of, since everything in order tracking is manual, and I have witnessed results with private health information being sent to the wrong offices. Their compliance is significantly lacking and orders sit for months and months with nothing being done.
Could not agree more! I'm most concerned about the fact they cut some of the highest performing reps, while hanging on to those providing no financial benefit to the company. Selection based solely on who Managers "liked" within first four months. When a company runs more like a clubhouse than a business, it's not in the best interest for investors nor employees. What a poor financial and cultural decision.